Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAshmore Group Regulatory News (ASHM)

Share Price Information for Ashmore Group (ASHM)

Share Price is delayed by 15 minutes
Get Live Data
202.20    -0.40 (-0.20%)
Bid:
202.00
Ask:
202.40
Spread: 0.40 (0.198%)
Market Cap: £1.31b
ASHM Live PriceLast checked at - London Stock Exchange

Intraday Ashmore Group Share Chart

Trading statement

12 Jul 2024 07:00

RNS Number : 1284W
Ashmore Group PLC
12 July 2024
 

Ashmore Group plc12 July 2024

FOURTH QUARTER ASSETS UNDER MANAGEMENT STATEMENT

Ashmore Group plc ("Ashmore", "the Group"), the specialist Emerging Markets asset manager, announces the following update to its assets under management ("AuM") in respect of the quarter ended 30 June 2024.

Assets under management

Theme

Actual31 March 2024

(US$ billion)

Estimated30 June 2024

(US$ billion)

Movement (%)

- External debt

7.1

7.2

+1%

- Local currency

17.4

17.7

+2%

- Corporate debt

4.9

4.7

-4%

- Blended debt

14.2

11.7

-18%

Fixed income

43.6

41.3

-5%

Equities

6.8

6.7

-1%

Alternatives

1.5

1.5

-

Total

51.9

49.5

-5%

 

Assets under management decreased by US$2.4 billion over the period, comprising negative investment performance of US$0.4 billion and net outflows of US$2.0 billion.

Emerging Markets returns have been positive over the past year and Ashmore has delivered outperformance across a broad range of strategies, but in contrast to this point in previous cycles, investor risk appetite remains subdued and institutional decisions to reduce Emerging Markets exposure continue to drive net outflows. This trend was notable in the blended debt theme this quarter, which, combined with small net outflows from corporate debt and equities, exceeded the net inflows into the local currency and external debt themes.

Market performance over the three months was broadly in line with the preceding quarter, with external debt, corporate debt and equity indices delivering positive returns, while local currency bond returns were held back by a stronger US dollar. Ashmore's relative outperformance was also consistent with that delivered in the previous three months.

Mark Coombs, Chief Executive Officer, Ashmore Group plc, commented:

"Emerging Markets have demonstrated resilience over the past few years, with effective monetary and fiscal policies underpinning superior GDP growth. Further growth is supported by structural economic reforms in many emerging countries. In contrast, the developed world faces numerous headwinds following a period of pro-cyclical fiscal expansion and a sharp increase in the cost of government debt. As the trajectories of emerging and developed countries continue to diverge, investor appetite for Emerging Markets exposure will improve and capital flows will follow, supporting higher risk-adjusted returns in Emerging Markets over the medium term."

 

Notes

Local currency AuM includes US$7.6 billion of AuM managed in overlay/liquidity strategies (31 March 2024: US$6.9 billion).

For the translation of US dollar-denominated balance sheet items, the GBP:USD exchange rate was 1.2641 at 30 June 2024 (30 June 2023: 1.2714). For the translation of US dollar management fees, the average GBP:USD exchange rate for the financial year was 1.2609 (FY2023: 1.2079).

Ashmore will announce its results in respect of the year ending 30 June 2024 on 5 September 2024.

 

For further information please contact:

Ashmore Group plcPaul MeasdayInvestor Relations +44 (0)20 3077 6278 ir@ashmoregroup.com

FTI ConsultingNeil Doyle +44 (0)7771 978 220Kit Dunford +44 (0)7717 417 038 ashmore@fticonsulting.com 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFEDDRILLIS
Date   Source Headline
28th May 202612:33 pmRNSDirector/PDMR Shareholding
16th Apr 20267:00 amRNSTrading Statement
1st Apr 202611:05 amRNSDirector/PDMR Shareholding
31st Mar 20267:00 amRNSAlliance
17th Mar 20263:36 pmRNSDirector/PDMR Shareholding
12th Feb 20264:25 pmRNSHolding(s) in Company
12th Feb 20267:00 amRNSHalf-year Financial Report
15th Jan 20267:00 amRNSTrading Statement
9th Dec 20252:12 pmRNSDirector/PDMR Shareholding
6th Nov 20252:34 pmRNSResult of AGM
14th Oct 20257:00 amRNSTrading Statement
9th Oct 20251:51 pmRNSHolding(s) in Company
25th Sep 20252:00 pmRNSNotice of AGM
19th Sep 20253:00 pmRNSDirector/PDMR Shareholding
19th Sep 20251:24 pmRNSDirector/PDMR Shareholding
18th Sep 202511:17 amRNSAnnual Financial Report
5th Sep 20257:00 amRNSFinal Results
14th Jul 20257:00 amRNSTrading Statement
11th Jul 20254:56 pmRNSHolding(s) in Company
30th Jun 20253:16 pmRNSDirectorate Change
23rd Jun 20252:20 pmRNSHolding(s) in Company
18th Jun 20255:18 pmRNSHolding(s) in Company
17th Jun 20254:15 pmRNSHolding(s) in Company
12th Jun 20259:36 amRNSHolding(s) in Company
10th Jun 20254:02 pmRNSHolding(s) in Company
6th Jun 20254:15 pmRNSHolding(s) in Company
6th Jun 202511:16 amRNSDirector/PDMR Shareholding
6th Jun 20259:00 amRNSHolding(s) in Company
4th Jun 20254:08 pmRNSHolding(s) in Company
27th May 20252:00 pmRNSHolding(s) in Company
14th Apr 20257:00 amRNSTrading Statement
7th Apr 20255:46 pmRNSDirector/PDMR Shareholding
31st Mar 20255:49 pmRNSDirector/PDMR Shareholding
18th Mar 202512:43 pmRNSDirector/PDMR Shareholding
18th Mar 202512:39 pmRNSDirector/PDMR Shareholding
26th Feb 20252:16 pmRNSHolding(s) in Company
26th Feb 20252:14 pmRNSHolding(s) in Company
7th Feb 20257:00 amRNSHalf-year Report
23rd Jan 202511:54 amRNSHolding(s) in Company
15th Jan 20257:00 amRNSTrading Statement
9th Jan 202511:32 amRNSHolding(s) in Company
9th Dec 20243:47 pmRNSDirector/PDMR Shareholding
7th Nov 20245:30 pmRNSDirector/PDMR Shareholding
6th Nov 20243:01 pmRNSResult of AGM
25th Oct 20242:04 pmRNSHolding(s) in Company
14th Oct 20247:00 amRNSTrading Statement
25th Sep 20249:38 amRNSNotice of AGM
17th Sep 20242:34 pmRNSAnnual Financial Report
16th Sep 20241:37 pmRNSDirector/PDMR Shareholding
5th Sep 20247:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.